Flavia P Linhares
Overview
Explore the profile of Flavia P Linhares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lage D, Machado A, Freitas C, Vale D, Linhares F, Cardoso J, et al.
Mol Immunol
. 2023 Feb;
155:79-90.
PMID: 36731193
Vaccination against visceral leishmaniasis (VL) should be considered as a safe and effective measure to disease control; however, few vaccines are available against canine VL and there is no an...
2.
Lage D, Vale D, Linhares F, Freitas C, Machado A, Cardoso J, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891310
Currently, there is no licensed vaccine to protect against human visceral leishmaniasis (VL), a potentially fatal disease caused by infection with Leishmania parasites. In the current study, a recombinant chimeric...
3.
Machado A, Lage D, Vale D, Freitas C, Linhares F, Cardoso J, et al.
Parasite Immunol
. 2022 Apr;
44(8):e12921.
PMID: 35437797
Treatment against visceral leishmaniasis (VL) presents problems by the toxicity of drugs, high cost and/or emergence of resistant strains. The diagnosis is hampered by variable sensitivity and/or specificity of tests....
4.
Lage D, Machado A, Vale D, Freitas C, Linhares F, Cardoso J, et al.
Cytokine
. 2022 Mar;
153:155865.
PMID: 35339043
Leishmania virulence proteins should be considered as vaccine candidates against disease, since they are involved in developing infection in mammalian hosts. In a previous study, a Leishmania guanosine-5'-triphosphate (GTP)-binding protein...
5.
Machado A, Lage D, Vale D, Freitas C, Linhares F, Cardoso J, et al.
Acta Trop
. 2022 Mar;
230:106412.
PMID: 35305943
Vaccination against visceral leishmaniasis (VL) should be considered as a control measure to protect against disease, and amastigote-specific proteins could help to develop such vaccines, since this parasite form is...